Valuation (7%) |
Company | Industry |
---|---|---|
P/E Ratio (TTM) | -18.75 | -15.27 |
PEG Ratio (TTM) | -0.19 | -4.35 |
P/S Ratio (TTM) | N/A | 45.97 |
P/B Ratio (TTM) | 6.00 | 28.96 |
P/FCF Ratio (TTM) | -26.03 | -2.59 |
Price to 5YR AVG Earnings Ratio | -16.74 | -5.56 |
Price to 5YR AVG FCF Ratio | -31.95 | -12.33 |
Profitability (25%) |
Company | Industry |
---|---|---|
ROA (TTM) | -29.34% | -19.06% |
ROE (TTM) | -30.63% | 15.70% |
Net Profit Margin (TTM) | N/A | -813.88% |
ROIC 5YR AVG | 1,005.77% | 3.12% |
Growth (0%) |
4QTR AVG | 3YR AVG | 5YR AVG |
---|---|---|---|
EPS | -0.84% | -13.93% | -10.68% |
Revenue | N/A | N/A | N/A |
Net Income | -3.26% | -31.62% | -24.09% |
Cash Flow | -1.32% | -34.96% | -19.86% |
Health (47%) |
Company | Industry |
---|---|---|
Current Ratio (TTM) | 12.04 | 5.56 |
Quick Ratio (TTM) | 12.04 | 5.34 |
D/E Ratio (TTM) | N/A | 0.95 |
Interest Coverage (TTM) | N/A | -6.44 |
Piotroski F-Score | 1 | 5 |
Altman Z-Score | 36.78 | 12.45 |
LTL to 5YR AVG FCF | N/A | 0.11 |
Shares Outstanding Growth 5YR AVG | 12.48% | 37.46% |